Published in Arch Gynecol Obstet on February 24, 2010
Health Services Research and Health Economy - Quality Care Training in Gynaecology, with Focus On Gynaecological Oncology. Geburtshilfe Frauenheilkd (2011) 1.60
Determinants of patient choice of healthcare providers: a scoping review. BMC Health Serv Res (2012) 1.33
The Patients' View On Accredited Breast Cancer Centers: Strengths and Potential for Improvement. Geburtshilfe Frauenheilkd (2012) 1.31
Relevance of health economics in breast cancer treatment - the view of certified breast centres and their patients. Breast Care (Basel) (2013) 0.97
What Influences Patients' Decisions When Choosing a Health Care Provider? Measuring Preferences of Patients with Knee Arthrosis, Chronic Depression, or Alzheimer's Disease, Using Discrete Choice Experiments. Health Serv Res (2015) 0.80
Impact of Patient and Procedure Mix on Finances of Perinatal Centres - Theoretical Models for Economic Strategies in Perinatal Centres. Geburtshilfe Frauenheilkd (2013) 0.77
Deciding Factors for the Referral of a Female Patient to a Specific Hospital from the Viewpoint of Practice-Based Specialists. Geburtshilfe Frauenheilkd (2015) 0.75
Factors contributing towards patient's choice of a hospital clinic from the patients' and managers' perspective. Electron Physician (2016) 0.75
IDENTIFYING ELEVEN FACTORS OF SERVICE MARKETING MIX (4PS) EFFECTIVE ON TENDENCY OF PATIENTS TOWARD PRIVATE HOSPITAL. Mater Sociomed (2016) 0.75
Novel endotheliotropic herpesviruses fatal for Asian and African elephants. Science (1999) 3.30
The A1 and A1B proteins of heterogeneous nuclear ribonucleoparticles modulate 5' splice site selection in vivo. Proc Natl Acad Sci U S A (1994) 2.92
Quality of diabetes care in community health centers. Am J Public Health (2000) 2.76
Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med (2000) 2.69
Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nat Genet (1998) 2.53
Activity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasma. Clin Pharmacol Ther (2011) 1.98
Retroviral integration within the Fli-2 locus results in inactivation of the erythroid transcription factor NF-E2 in Friend erythroleukemias: evidence that NF-E2 is essential for globin expression. Proc Natl Acad Sci U S A (1994) 1.84
Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res (1990) 1.77
The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am J Pathol (2001) 1.73
Retroviral insertions downstream of the heterogeneous nuclear ribonucleoprotein A1 gene in erythroleukemia cells: evidence that A1 is not essential for cell growth. Mol Cell Biol (1992) 1.70
Patients' attitudes to totally implantable venous access port systems for gynecological or breast malignancies. Eur J Surg Oncol (2006) 1.61
Fetal adrenal haemorrhage--two-dimensional and three-dimensional imaging. Fetal Diagn Ther (2007) 1.57
Barriers to providing diabetes care in community health centers. Diabetes Care (2001) 1.52
Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int Arch Occup Environ Health (2007) 1.50
Macrosomia: a new formula for optimized fetal weight estimation. Ultrasound Obstet Gynecol (2010) 1.48
Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation. Am J Pathol (1999) 1.41
[Sebaceous breast carcinoma: report of a rare histological special subtype]. Pathologe (2014) 1.39
Factors correlating with reexcision after breast-conserving therapy. Eur J Surg Oncol (2008) 1.37
Molecular basis of glycoalkaloid induced membrane disruption. Biochim Biophys Acta (1995) 1.28
Negative regulation of CD4 expression in T cells by the transcriptional repressor ZEB. Int Immunol (1999) 1.24
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2. Br J Cancer (2012) 1.13
Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis. Genes Chromosomes Cancer (1997) 1.13
Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer. J Cancer Res Clin Oncol (2008) 1.13
Defining CD95 as a tumor suppressor gene. J Mol Med (Berl) (2000) 1.13
Insights into the molecular biology of the estrogen receptor define novel therapeutic targets for breast cancer. Eur J Endocrinol (2004) 1.09
Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44). Ann Oncol (2013) 1.09
TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1. Oncogene (1996) 1.09
Awareness of breast cancer incidence and risk factors among healthy women. Eur J Cancer Prev (2004) 1.08
Gene amplification and expression of the steroid receptor coactivator SRC3 (AIB1) in sporadic breast and endometrial carcinomas. Horm Metab Res (2001) 1.06
The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res (1995) 1.06
The concept of the certification system of the German Cancer Society and its impact on gynecological cancer care. Arch Gynecol Obstet (2013) 1.05
Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers. J Surg Oncol (2007) 1.03
Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer. Genes Chromosomes Cancer (1996) 1.02
p73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis. Oncogene (2001) 1.02
Hormones and hormone antagonists: mechanisms of action in carcinogenesis of endometrial and breast cancer. Horm Metab Res (2001) 1.01
Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies. Support Care Cancer (2007) 1.01
ERBB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin-embedded breast carcinoma tissues. Int J Cancer (1995) 1.00
Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol (2007) 1.00
[HPV-associated alterations of the vulva and vagina. Morphology and molecular pathology]. Pathologe (2011) 1.00
Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial. Ann Oncol (2010) 0.99
Endothelial leukocyte adhesion molecule-1-dependent adhesion of colon carcinoma cells to vascular endothelium is inhibited by an antibody to Lewis fucosylated type I carbohydrate chain. Lab Invest (1992) 0.99
Fertility preservation in cancer patients. Minerva Ginecol (2010) 0.98
Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial. Ann Oncol (2010) 0.98
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium. Br J Cancer (2014) 0.96
Correlations between anti-müllerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes. Eur J Med Res (2007) 0.94
Association of blood group A with early-onset ovarian hyperstimulation syndrome. Transfus Clin Biol (2008) 0.94
Ontogenetic scaling of foot musculoskeletal anatomy in elephants. J R Soc Interface (2008) 0.94
Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome. Hum Reprod (2009) 0.94
Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): therapeutic implications. Oncogene (2000) 0.94
Posttranscriptional stimulation of endothelial cell matrix metalloproteinases 2 and 1 by endothelioma cells. Exp Cell Res (2000) 0.93
Free-operant performance on variable interval schedules with a linear feedback loop: no evidence for molar sensitivities in rats. J Exp Psychol Anim Behav Process (2000) 0.92
Assessment of breast cancer tumor size depends on method, histopathology and tumor size itself*. Breast Cancer Res Treat (2005) 0.92
[Inflammation of the myocardium as an arrhythmia trigger]. Z Kardiol (2000) 0.92
Differentiation between phyllodes tumor and fibroadenoma using real-time elastography. Ultraschall Med (2011) 0.91
Tip60 is a cell-type-specific transcriptional regulator. J Biochem (2001) 0.91
Growth inhibition of xenotransplanted human carcinomas by a monoclonal antibody directed against the epidermal growth factor receptor. Eur J Cancer (1994) 0.90
CDKN2A gene inactivation in epithelial sporadic ovarian cancer. Br J Cancer (1999) 0.89
Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy. J Cancer Res Clin Oncol (2008) 0.89
Psychosomatic aspects of urinary incontinence. Arch Gynecol Obstet (1999) 0.88
Endogenous retroviral syncytin: compilation of experimental research on syncytin and its possible role in normal and disturbed human placentogenesis. Mol Hum Reprod (2004) 0.88
Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist. Exp Clin Endocrinol Diabetes (2005) 0.88
Disturbed Wnt Signalling due to a Mutation in CCDC88C Causes an Autosomal Recessive Non-Syndromic Hydrocephalus with Medial Diverticulum. Mol Syndromol (2010) 0.88
DNA sequence variations of the entire anti-Mullerian hormone (AMH) gene promoter and AMH protein expression in patients with the Mayer-Rokitanski-Kuster-Hauser syndrome. Hum Reprod (2004) 0.88
Structural and functional studies on the transformation of the intestinal mucosa in rats with experimental diabetes. Res Exp Med (Berl) (1977) 0.88
Trans-placental exposure of neonates to acrylamide--a pilot study. Int Arch Occup Environ Health (2004) 0.87
Comparison of xenografting in SCID mice and LIVE/DEAD assay as a predictor of the developmental potential of cryopreserved ovarian tissue. In Vivo (2006) 0.87
Phenotypic and functional characteristics of tumour-derived microvascular endothelial cells. Clin Exp Metastasis (1999) 0.86
Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone. Exp Clin Endocrinol Diabetes (2006) 0.86
Modulation of tumor angiogenesis by conditional expression of fibroblast growth factor-2 affects early but not established tumors. Cancer Res (2001) 0.86
Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trial. Br J Cancer (2012) 0.86
CD95 ligand expression as a mechanism of immune escape in breast cancer. Immunology (2000) 0.86
Prognostic significance of the detection of human papilloma virus L1 protein in smears of mild to moderate cervical intraepithelial lesions. Eur J Obstet Gynecol Reprod Biol (2008) 0.86
The p44S10 locus, encoding a subunit of the proteasome regulatory particle, is amplified during progression of cutaneous malignant melanoma. Oncogene (2000) 0.85
Differences in gene expression dependent on sampling site in placental tissue of fetuses with intrauterine growth restriction. Placenta (2010) 0.85
'Proteolytic switching': opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression. Br J Cancer (1999) 0.85
Acute promyelocytic leukemia and pregnancy. Eur J Haematol (2000) 0.84
Psychosomatic aspects of vulvodynia. Comparison with the chronic pelvic pain syndrome. J Reprod Med (1999) 0.84
Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40--GeparQuattro). Ann Oncol (2013) 0.84
Expression of the soluble vascular endothelial growth factor receptor-1 in cutaneous melanoma: role in tumour progression. Br J Dermatol (2011) 0.83